Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
about
Prostate MRI - an update for the referring urologistWhen prostate cancer remains undetectable: The dilemmaThe role of magnetic resonance imaging in the diagnosis and management of prostate cancerScreening and detection advances in magnetic resonance image-guided prostate biopsyRole of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancerTargeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive TechnologyMultiparametric MRI in biopsy guidance for prostate cancer: fusion-guidedAnti-Oligomannose Antibodies as Potential Serum Biomarkers of Aggressive Prostate CancerMagnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathologyUpgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.Review by urological pathologists improves the accuracy of Gleason grading by general pathologists.Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype'Insignificant' prostate cancer on biopsy: pathologic results from subsequent radical prostatectomy.Magnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancerKnife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostateProstate cancer risk inflation as a consequence of image-targeted biopsy of the prostate: a computer simulation study.State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer.Improving the Gleason grading accuracy of transrectal ultrasound-guided biopsy.MRI-targeted prostate biopsy: a review of technique and results.Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists?Prostate-specific antigen-based prostate cancer screening: Past and future.Predictive factors of Gleason score upgrading in localized and locally advanced prostate cancer diagnosed by prostate biopsy.The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database.miRNAs dysregulated in association with Gleason grade regulate extracellular matrix, cytoskeleton and androgen receptor pathways.Prostate-specific antigen 10-20 ng/mL: A predictor of degree of upgrading to ≥8 among patients with biopsy Gleason score 6.Clarifying the PSA grey zone: The management of patients with a borderline PSA.Development and External Validation of a Nomogram Predicting the Probability of Significant Gleason Sum Upgrading among Japanese Patients with Localized Prostate Cancer.Pathologic correlation of transperineal in-bore 3-Tesla magnetic resonance imaging-guided prostate biopsy samples with radical prostatectomy specimen.Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach.A nomogram to predict Gleason sum upgrading of clinically diagnosed localized prostate cancer among Chinese patients.A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling.The prostate cancer risk calculator from the Prostate Cancer Prevention Trial underestimates the risk of high grade cancer in contemporary referral patients.Predictors of Gleason score upgrading in patients with prostate biopsy Gleason score ≤6.Clinical and pathological variables that predict changes in tumour grade after radical prostatectomy in patients with prostate cancerUpgrading of Gleason score on radical prostatectomy specimen compared to the pre-operative needle core biopsy: an Indian experience.PREDICT: model for prediction of survival in localized prostate cancer.Development and Phantom Validation of a 3-D-Ultrasound-Guided System for Targeting MRI-Visible Lesions During Transrectal Prostate Biopsy.Predictors of Gleason Score (GS) upgrading on subsequent prostatectomy: a single Institution study in a cohort of patients with GS 6.Detection, localisation and characterisation of prostate cancer by prostate HistoScanning(™).
P2860
Q26739725-9B57B7D0-FE62-435D-9DB4-06B58DD1F9C0Q26795515-13A75041-B33A-4369-A9D7-D28FE46594F1Q26849794-8090CD31-3715-42FF-825D-493ADF7E37BFQ26991785-B2FD6832-A516-4EC8-94A8-28B8EBFDA748Q26998938-64CC9FA7-AAE2-4984-9D19-968F1BC20D37Q27008215-07F2733A-8670-4B90-B414-C219879A32C8Q27010554-98A7F58A-F8E8-4789-BA7D-B96AE6E18BF5Q34069601-841878BB-E4AC-4E7A-BBC1-019060184DA5Q34364108-1DF81C03-1C05-4DFB-9CF2-549738E6B769Q34825072-DC58D0CC-C5E2-49EF-87F2-7076CCCC5C22Q35706065-20EBE970-CB1D-4559-930B-5C52B58E1209Q36048692-C5CA09CF-D79C-4BA3-A84A-26E6B756C396Q36614710-5B3E9B24-0739-492B-AD96-BE62FDE2C0E8Q36771260-B7A0F10F-7F65-4BAA-B3AE-FA792786D9DEQ37018444-9B8F5228-E487-4A3B-884F-FC6B8444636EQ37476982-EB45EB28-D4E4-4A7F-B4E7-7DF845866BADQ37587129-06E5838D-9229-4664-A585-9C1B73EB2434Q37878465-CAF2882C-0D80-47A9-9B2A-F841F9DEF0B3Q38121878-A191C4AD-D1FA-4547-A6A0-D61F623853C2Q38141793-E5CF52C5-4776-4D30-A832-3B52EE24BE9BQ38356614-595E55FB-68C2-4017-B2A6-7219607AB057Q38408501-EE783BD5-6C29-4F39-BC7D-8CC3F75C1DF9Q38480152-B7D706E5-2F42-48D4-9575-8568DF4ADF32Q38625047-B0095004-8912-4F81-A21D-8C4ABE856941Q38870815-73ADD355-5D16-431D-BE0A-C6B5C74884F9Q38928232-92DF686C-C283-4C52-B1BB-24A91716275AQ38965360-60DDFEAC-CA52-476C-A9D1-33B750044225Q39105066-F133B35C-0883-4733-ACB9-418772B6B6AFQ39178750-96839257-554D-4B87-ACDB-1378BCE62A61Q39191190-74D0BEBC-2B7D-4538-A7C8-B37A629DCD98Q39753928-563EF71B-BBCC-401B-BE7E-7DD93638254DQ39896943-38D883CA-9186-4761-AB11-794937F62554Q39963357-3D169255-5E06-4F29-B659-BFC0E183768CQ40100863-4AEDAA3D-0A60-4A84-A34D-098D752E4A09Q40612914-D488B6CE-EC82-4388-A99A-08E99DE4378DQ40811341-0960C486-5130-41DB-B39D-B4B54C307834Q41288229-BFD61E93-2BA3-4623-A97E-5245B8E8879AQ41643652-98F439C5-D019-473A-BA82-18C4CD2C0A73Q41863428-5DCBE3F0-98E0-4288-B883-C50C645130B8Q42625443-0959E818-6605-4676-9782-D644DAC87A2F
P2860
Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Extended prostate biopsy schem ...... ons for radiotherapy patients.
@en
Extended prostate biopsy schem ...... ons for radiotherapy patients.
@nl
type
label
Extended prostate biopsy schem ...... ons for radiotherapy patients.
@en
Extended prostate biopsy schem ...... ons for radiotherapy patients.
@nl
prefLabel
Extended prostate biopsy schem ...... ons for radiotherapy patients.
@en
Extended prostate biopsy schem ...... ons for radiotherapy patients.
@nl
P2093
P1476
Extended prostate biopsy schem ...... ons for radiotherapy patients.
@en
P2093
Christopher R King
Harcharan Gill
John E McNeal
Joseph C Presti
P304
P356
10.1016/J.IJROBP.2003.10.014
P407
P577
2004-06-01T00:00:00Z